Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: A systematic review
Head and neck cancers are highly prevalent worldwide. Most of these lesions are diagnosed in the advanced stages of the disease. Thus, they do not often have a good long-term prognosis. Like other cancer types, head and neck cancers are managed by surgery, radiotherapy, and chemotherapy. Despite sig...
Saved in:
Main Authors: | Fatemeh Atashi (Author), Nafiseh Vahed (Author), Parya Emamverdizadeh (Author), Shirin Fattahi (Author), Ladan Paya (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
by: Stefano Cavalieri, et al.
Published: (2021) -
Docetaxel in the treatment of squamous cell carcinoma of the head and neck
by: Alexander Rapidis, et al.
Published: (2008) -
MAPKs activation in head and neck squamous cell carcinomas
by: Daniele Maggioni, et al.
Published: (2011) -
Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma
by: Fayette J, et al.
Published: (2015) -
Efficacy of docetaxel, cisplatin, and 5-fluorouracil as an induction chemotherapy in oral squamous cell carcinoma in a tertiary hospital in Saudi Arabia
by: Mohammad Alessa, et al.
Published: (2024)